TVTX - Travere falls after Phase 3 data for kidney disease candidate
2023-09-21 08:04:57 ET
More on CSL, Travere, etc.
- CSL: Watch Out For Positive Surprises
- CSL Limited (CSLLY) Q4 2023 Earnings Call Transcript
- Travere Boosts Cash Position As Investors Brace For Filspari Data
- Travere Therapeutics, Inc. (TVTX) Q2 2023 Earnings Call Transcript
- Arcturus, CSL granted EU review for COVID vaccine
For further details see:
Travere falls after Phase 3 data for kidney disease candidate